Ticker
SGHT
Analysis
Sight Sciences, Inc. (SGHT) Stock Analysis
Sight Sciences, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysis connected to SGHT.
Sight Sciences, Inc.
Sight Sciences, Inc. investors can use 6ix to track stock price context, company news, investor events, webinar replays, and AI-assisted analysisconnected to SGHT.
Stock profile
Asset type
Stock
Market cap
$287.3M
Sector
Health Technology
Industry
Medical Specialties
Currency
USD
Ticker listings
Sight Sciences, Inc. may appear across multiple exchanges or ticker formats. 6ix consolidates those listings around the canonical analysis page for discovery.
- SGHT primary listing
Latest Sight Sciences, Inc. news
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing...
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
MENLO PARK, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing a...
Sight Sciences’ Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 202...
MENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commerc...
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developi...
Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury’s Verdict and Awards Monetary Damages to Sight Sciences Agains...
Court preserves jury’s finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028ME...
Research sections
Valuation
Review valuation context for Sight Sciences, Inc..
Future growth
Review future growth context for Sight Sciences, Inc..
Past performance
Review past performance context for Sight Sciences, Inc..
Financial health
Review financial health context for Sight Sciences, Inc..
Dividend
Review dividend context for Sight Sciences, Inc..
Management
Review management context for Sight Sciences, Inc..
Ownership
Review ownership context for Sight Sciences, Inc..
Other information
Review other information context for Sight Sciences, Inc..
Community
Review community context for Sight Sciences, Inc..